AGENDA
Welcome & Introductions
Joan Chen, MD, MS and Colin Howden, MD
Overview and Diagnosis of GERD
Overview of GERD burden, natural history, and complications; review of current guidelines for GERD diagnosis
Joan Chen, MD, MS
Traditional Management of GERD
Review of current guidelines for GERD management; discussion of limitations of PPIs in GERD management; brief coverage of surgical/endoscopic approaches
Michael Vaezi, MD, PhD, MSc, FACG
Emerging Medical Therapies in GERD
Overview of P-CAB pharmacology and latest evidence regarding clinical safety and efficacy in EE and NERD
Colin Howden, MD
Q&A/Closing Remarks
Michael Vaezi, MD, PhD, MSc, FACG
Program overview/goal statement
This live broadcast experience will provide education on the latest emerging data for the management and treatment of gastroesophageal reflux disease (GERD); erosive esophagitis (EE) and non-erosive reflux disease (NERD).
Target audience
This activity has been designed to meet the educational needs of gastroenterologists, nurse practitioners, physician assistants, and allied health and primary care providers involved in the care of patients with GERD; management and treatment of EE and NERD.
Educational objectives
-
Summarize current treatment recommendations for GERD management
-
Describe the limitations of current therapies in GERD management and potential consequences of sub-optimally treated disease
-
Summarize the clinical implications of the pharmacologic and pharmacokinetic differences between PPIs and P-CABs
-
Describe the latest clinical trial data evaluating the efficacy and safety of P-CABs in managing GERD
Accreditation statements
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and the Gi Health Foundation (GiHF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medical Education Resources designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER and GiHF planners have no relevant financial relationships to disclose.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Gi Health Foundation (GiHF), and Phathom Pharmaceuticals, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee information
There is no fee for this educational activity.
Jointly provided by Medical Education Resources and the Gi Health Foundation.
Supported by an educational grant from Phathom Pharmaceuticals, Inc.
